HK:3933 Stock Latest News
PremiumCompany AnnouncementsUnited Laboratories Announces 2025 AGM Agenda United Laboratories’ Cefotaxime Sodium Gains Approval United Laboratories Announces HK$200 Million Share Buy-Back Plan PremiumCompany AnnouncementsUnited Laboratories’ Eye Drops Gain Approval, Boosting Ophthalmic Portfolio United Laboratories to Review Annual Results and Dividend Proposal United Laboratories’ UBT251 Injection Gains FDA Approval for CKD Trials PremiumCompany AnnouncementsUnited Laboratories’ Antibiotic Gains Key Approval United Laboratories Acquires Award Shares Under Scheme United Laboratories’ Antibiotic Product Gains Key Approval